Dr. MacSweeney, a Consultant Interventional Neuro-Radiologist, is a world-renowned expert on the available treatments for Alzheimer’s and has been involved from the early days of clinical trials in both the UK and the US. She was the first clinician in Europe to administer Amyloid Targeting Therapy (ATT) drugs to patients outside of a clinical trial, and Re:Cognition Health is one of, if not the, biggest providers of ATT medications in Europe.She co-founded Re:Cognition Health in 2011 to provide a specialist service for accurate diagnosis and access to the latest treatments for progressive neurodegenerative and neurodevelopmental conditions and traumatic brain injury.Dr. MacSweeney and Re:Cognition Health’s expertise has been recognized with more than 40 prestigious and international accolades, including: Inc. Female Founders 500 2026, Diagnostics Provider of the Year at the 2025 HealthInvestor Awards, Winner – Best in Healthcare Outcomes, LaingBuisson 2025, Leaders in Law, Cognitive Health Expert of the Year 2024/25, Global 100 2023 Best Health Research Company of the Year UK 2023, EY Entrepreneur of the Year Winner- Societal Impact 2019 (London and South England), and KPMG Entrepreneur of the Year Winner 2016.
